| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |